메뉴 건너뛰기




Volumn 77, Issue SUPPL. 2, 2006, Pages 32-35

A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B

Author keywords

Acute leukaemia; Fungal infections; Fusarium; Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUCONAZOLE; FLUDARABINE; IMATINIB; ITRACONAZOLE; MELPHALAN; PROTEIN P190; RITUXIMAB; TENIPOSIDE; THYROGLOBULIN ANTIBODY; VORICONAZOLE;

EID: 33845322267     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (14)
  • 2
    • 1642363501 scopus 로고    scopus 로고
    • Infections due to emerging and uncommon medically important fungal pathogens
    • Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (suppl 1): 48-66.
    • (2004) Clin Microbiol Infect , vol.10 , Issue.SUPPL. 1 , pp. 48-66
    • Walsh, T.J.1    Groll, A.2    Hiemenz, J.3
  • 3
    • 2342455726 scopus 로고    scopus 로고
    • Fusarium infection in hematopoietic stem cell transplant recipients
    • Nucci M, Marr KA, Queiroz-Telles F, et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38: 1327-42.
    • (2004) Clin Infect Dis , vol.38 , pp. 1327-1342
    • Nucci, M.1    Marr, K.A.2    Queiroz-Telles, F.3
  • 4
    • 0030737627 scopus 로고    scopus 로고
    • Fusarium, a significant emerging pathogen in patients with hematological malignancy: Ten years' experience at a cancer center and implications for management
    • Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematological malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
    • (1997) Blood , vol.90 , pp. 999-1008
    • Boutati, E.I.1    Anaissie, E.J.2
  • 5
    • 0037108390 scopus 로고    scopus 로고
    • Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management
    • Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-20.
    • (2002) Clin Infect Dis , vol.35 , pp. 909-920
    • Nucci, M.1    Anaissie, E.2
  • 6
    • 0026647959 scopus 로고
    • Efficacy of liposomal amphotericin B (Ambisome®) in the eradication of Fusarium infection in a leukaemic patient
    • Cofrancesco E, Boschetti C, Viviani MA, et al. Efficacy of liposomal amphotericin B (Ambisome®) in the eradication of Fusarium infection in a leukaemic patient. Haematologica 1992; 77: 280-3.
    • (1992) Haematologica , vol.77 , pp. 280-283
    • Cofrancesco, E.1    Boschetti, C.2    Viviani, M.A.3
  • 7
    • 17344368128 scopus 로고    scopus 로고
    • Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
    • Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383-96.
    • (1998) Clin Infect Dis , vol.26 , pp. 1383-1396
    • Walsh, T.J.1    Hiemenz, J.W.2    Seibel, N.L.3
  • 8
    • 0028218069 scopus 로고
    • Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation
    • Ellis ME, Clink H, Younge D, et al. Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation. Scand J Infect Dis 1994; 26: 225-8.
    • (1994) Scand J Infect Dis , vol.26 , pp. 225-228
    • Ellis, M.E.1    Clink, H.2    Younge, D.3
  • 9
    • 0032835908 scopus 로고    scopus 로고
    • Fusarium infections in patients with severe aplastic anemia: Review and implications for management
    • Girmenia C, Iori AP, Boecklin F, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica 1999; 84: 114-8.
    • (1999) Haematologica , vol.84 , pp. 114-118
    • Girmenia, C.1    Iori, A.P.2    Boecklin, F.3
  • 10
    • 0027227955 scopus 로고
    • Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex
    • Engelhard D, Eldor A, Polacheck I, et al. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma 1993; 9: 385-92.
    • (1993) Leuk Lymphoma , vol.9 , pp. 385-392
    • Engelhard, D.1    Eldor, A.2    Polacheck, I.3
  • 11
    • 0036784325 scopus 로고    scopus 로고
    • In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results
    • Paphitou NL, Ostrosky-Zeichner L, Paetznick VL, et al. In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results. Antimicrobial Agents and Chemotherapy 2002; 46: 3298-300.
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , pp. 3298-3300
    • Paphitou, N.L.1    Ostrosky-Zeichner, L.2    Paetznick, V.L.3
  • 12
    • 0036205764 scopus 로고    scopus 로고
    • Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
    • Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrobial Agents and Chemotherapy 2002; 46: 1032-7.
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , pp. 1032-1037
    • Pfaller, M.A.1    Messer, S.A.2    Hollis, R.J.3
  • 13
    • 0038556830 scopus 로고    scopus 로고
    • Voriconazole treatment for less-common, emerging, or refractory fungal infections
    • Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122-31.
    • (2003) Clin Infect Dis , vol.36 , pp. 1122-1131
    • Perfect, J.R.1    Marr, K.A.2    Walsh, T.J.3
  • 14
    • 33750605303 scopus 로고    scopus 로고
    • Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B
    • Mar 31; [Epub ahead of print]
    • Stanzani M, Vianelli N, Bandini G, et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006 Mar 31; [Epub ahead of print]
    • (2006) J Infect
    • Stanzani, M.1    Vianelli, N.2    Bandini, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.